Lung infections fall into several broad categories based on what causes them and where in the respiratory tract they take hold. The major types are bacterial, viral, fungal, and mycobacterial infections, each with distinct behavior, risk profiles, and treatment approaches. Lower respiratory infections, which include pneumonia, bronchitis, and bronchiolitis, remain among the leading causes of death worldwide, responsible for roughly 2.18 million deaths globally in 2021.1The Lancet Infectious Diseases. Global, regional, and national burden of lower respiratory infections and their aetiologies, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 Understanding the different types helps explain why symptoms, severity, and treatment can vary so dramatically from one lung infection to another.
Bacterial Lung Infections
Bacteria are the classic cause of pneumonia and remain the single largest contributor to deaths from lower respiratory infections. Streptococcus pneumoniae alone was responsible for more lower respiratory infection deaths than all other causes combined in a 2016 global analysis.2PubMed Central. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of lower respiratory infections in 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 Other common bacterial culprits include Haemophilus influenzae, Staphylococcus aureus, and Pseudomonas aeruginosa.3PubMed Central. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience
Bacterial pneumonia typically develops when germs breach the airway defenses and colonize the tiny air sacs of the lungs, triggering inflammation, fluid buildup, and consolidation of lung tissue. Symptoms tend to come on relatively fast: high fever, productive cough with colored sputum, chest pain that worsens with breathing, and sometimes shortness of breath. Antibiotics are the standard treatment, but the specific drug matters a great deal because resistance patterns vary by germ and by setting.
Where You Caught It Changes the Bug
One of the most important distinctions in bacterial pneumonia is whether you picked it up in everyday life or in a healthcare setting. Community-acquired pneumonia, the kind you develop at home or at work, is most often caused by Streptococcus pneumoniae and responds well to common antibiotics. Healthcare-associated pneumonia, which develops in people recently hospitalized, living in nursing homes, or receiving outpatient treatments like dialysis, tends to involve tougher organisms. In one large study, the most common pathogen in healthcare-associated cases was methicillin-resistant Staphylococcus aureus (MRSA), and drug-resistant gram-negative bacteria showed up far more often than in community cases.3PubMed Central. Health care-associated pneumonia and community-acquired pneumonia: a single-center experience
This matters for treatment because patients with healthcare-associated pneumonia receive inappropriate initial antibiotics more frequently and have higher mortality than those with community-acquired pneumonia.4International Journal of Infectious Diseases. Healthcare-associated pneumonia (HCAP): A critical appraisal If you or a family member develop pneumonia symptoms shortly after a hospital stay or while receiving regular medical care, that context is important information to share with your doctor, because it may shift which antibiotics are started first.
Viral Lung Infections
Viruses cause the majority of respiratory illnesses across all age groups. Most viral respiratory infections stay in the upper airways as a common cold and resolve on their own, but a fraction spreads deeper into the lungs, causing bronchiolitis or viral pneumonia. The viruses most responsible for severe lower respiratory illness are influenza, respiratory syncytial virus (RSV), and, since 2019, SARS-CoV-2.5Hunter’s Tropical Medicine and Emerging Infectious Diseases. Viral Respiratory Infections
Viral pneumonia can look different from bacterial pneumonia. The fever may be lower, the cough is often dry rather than productive, and imaging sometimes shows a diffuse, hazy pattern in both lungs rather than a dense consolidation in one area. Some viral infections, like influenza, can also set the stage for a secondary bacterial pneumonia that arrives days after the initial viral illness seems to be improving, so a relapse of fever and worsening cough after brief improvement should raise a red flag.
In young children, RSV stands out as the dominant cause of bronchiolitis, an infection that inflames and obstructs the small airways. RSV bronchiolitis is the leading reason previously healthy infants are admitted to hospitals.6PubMed Central. Respiratory syncytial virus (RSV) and its propensity for causing bronchiolitis Elderly adults face a similarly elevated risk from viral lung infections, especially influenza and RSV, because immune function declines with age.
Fungal Lung Infections
Fungal infections of the lungs are far less common than bacterial or viral ones in healthy people, but they become a serious concern for anyone with a weakened immune system. People being treated for cancer, organ transplant recipients on immunosuppressive drugs, and those with inherited immune deficiencies are all at increased risk.7PubMed. Fungal lung disease In these groups, fungal lung infections can be severe and life-threatening.
In people with intact immune systems, fungal lung infections most often involve the so-called endemic mycoses, which are caused by fungi that live in specific geographic regions. Histoplasma, for example, thrives in soil enriched with bat or bird droppings and is common in river valleys of the central United States. Coccidioides lives in arid soils of the American Southwest and parts of Latin America. Valley fever, caused by Coccidioides, can produce a pneumonia-like illness after inhaling fungal spores stirred up from dry dirt. Most healthy people recover without antifungal treatment, but a small percentage develop chronic or disseminated disease.
Aspergillus is another fungus worth knowing about. Its spores are everywhere in the environment and harmless to most people, but in those with pre-existing lung cavities (from tuberculosis or other causes) it can form fungal balls called aspergillomas. In severely immunocompromised patients, Aspergillus can cause invasive disease that spreads through lung tissue rapidly.
Mycobacterial Infections
Tuberculosis, caused by Mycobacterium tuberculosis, is the most famous mycobacterial lung infection and still one of the world’s deadliest infectious diseases. It spreads through airborne droplets when an infected person coughs, and it can lie dormant in the body for years before becoming active disease. Active pulmonary TB typically causes a persistent cough lasting weeks, night sweats, weight loss, and sometimes coughing up blood. Treatment requires multiple antibiotics taken for months, and drug-resistant TB is an escalating global concern.
Less familiar but increasingly recognized are infections caused by nontuberculous mycobacteria (NTM). These are environmental organisms found in soil and water that can cause chronic lung disease, particularly in older adults and people with pre-existing lung conditions. NTM lung disease has a very gradual onset: because these organisms grow slowly and have low virulence, the incubation period can stretch from months to years, making the source of infection nearly impossible to trace.8Frontiers in Immunology. The Rise of Non-Tuberculosis Mycobacterial Lung Disease
NTM lung disease takes several forms. One pattern creates cavities in the upper lobes that can look similar to TB on imaging. Another pattern, more common in women without typical TB risk factors, causes nodules and widened airways (bronchiectasis), often in the middle lobe of the right lung and the lingula of the left lung.9PubMed Central. CT Imaging Characteristics of Nontuberculous Mycobacteria Lung Disease, Active Tuberculosis and Multi-Drug Resistant Tuberculosis This specific pattern on a CT scan can help doctors distinguish NTM from TB, though cultures and lab testing are still needed to confirm the diagnosis.
Aspiration Pneumonia
Aspiration pneumonia develops when material from the mouth or stomach is inhaled into the lungs. This could be saliva, food particles, or gastric contents, and it tends to happen in people whose natural protective reflexes are impaired. Alcoholism and swallowing difficulties after a stroke are two classic risk factors.10PubMed. Aspiration pneumonia and primary lung abscess: diagnosis and therapy of an aerobic or an anaerobic infection?
What makes aspiration pneumonia distinct is the role of anaerobic bacteria. The mouth naturally harbors anaerobic organisms that cause no harm in the oral cavity but wreak havoc in the lungs.11JAMA. Treatment of Aspiration Pneumonia and Primary Lung Abscess: Penicillin G vs Clindamycin The early course of aspiration pneumonia can be vague and hard to pin down. It is only after one to two weeks that the telltale complications appear: tissue death within the lung, abscess formation, and a foul-smelling discharge that is characteristic enough to be almost diagnostic.10PubMed. Aspiration pneumonia and primary lung abscess: diagnosis and therapy of an aerobic or an anaerobic infection? Because of this delayed presentation, aspiration pneumonia is sometimes missed early and diagnosed only when a lung abscess has already formed.
How the Body Fights Back
When a pathogen reaches the lungs, the immune response follows a remarkably organized sequence. Classic studies of bacterial pneumonia showed that the infection spreads outward from its starting point, creating concentric zones: an advancing edge filled with fluid and free-floating bacteria, then a zone where white blood cells are actively engulfing the germs, and finally an inner zone where the immune system has already cleared the organisms and resolution is beginning.12Journal of Experimental Medicine. Studies on the Mechanism of Recovery in Pneumococcal Pneumonia
With highly virulent pathogens, the immune response can itself become destructive. Research on H5N1 avian influenza showed that within 24 hours of infection, the virus produced severe damage to the airways and air sacs, targeting a specific type of cell crucial for lung repair. The result was a massive, sustained inflammatory response that interfered with the body’s own immune regulation and caused far more tissue destruction than less virulent strains.13PubMed Central. Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus This phenomenon helps explain why some pneumonias escalate to acute respiratory distress syndrome, a life-threatening condition where the lungs fill with fluid and can no longer exchange oxygen efficiently.
Lung Infections in People With Weakened Immune Systems
People with compromised immune systems face a wider spectrum of potential lung infections than the general population.14Annals of the American Thoracic Society. Immunocompromised Host Pneumonia: Definitions and Diagnostic Criteria: An Official American Thoracic Society Workshop Report On top of all the usual suspects, they are vulnerable to opportunistic pathogens that a healthy immune system easily holds in check. Pneumocystis jirovecii, for instance, causes a diffuse pneumonia almost exclusively in immunocompromised hosts and was one of the earliest recognized complications of HIV/AIDS. Cytomegalovirus, a virus that silently infects most adults without causing disease, can reactivate and cause severe pneumonia in transplant recipients.
The challenge for clinicians is that immunocompromised patients often present with atypical symptoms. Fever may be blunted by the very drugs suppressing their immune system, and the usual inflammatory signs on chest imaging can be subtle or absent. The diagnostic workup therefore tends to be more aggressive, sometimes involving bronchoscopy or CT-guided lung biopsy to identify the pathogen. Combined approaches using biopsy tissue with molecular testing have been shown to improve pathogen detection rates over conventional methods alone.15Journal of Radiation Research and Applied Sciences. Computed tomography imaging-guided lung biopsy and tissue culture applied in the diagnosis of pulmonary infectious diseases
Diagnosing Lung Infections
Figuring out which pathogen is responsible for a lung infection has traditionally relied on growing organisms from sputum or blood in a lab, a process that can take days and often fails to yield a result. Newer rapid PCR-based panels have changed this landscape. One study found that a syndromic PCR panel detected a probable causative pathogen in about 94% of relevant cases, compared to roughly 69% with standard diagnostic methods.16Scientific Reports. Rapid syndromic PCR testing in patients with respiratory tract infections reduces time to results and improves microbial yield Faster identification means doctors can narrow antibiotic therapy sooner, reducing unnecessary broad-spectrum drug use and potentially curbing the development of resistance.
Even the quality of the sputum sample you cough up matters. Labs have traditionally used microscopic quality checks to decide whether a sample is worth culturing. Interestingly, research with newer PCR panels found that samples considered “low quality” by traditional standards still contained clinically relevant bacteria. Discarding those samples would have meant missing important infections.17PubMed Central. The diagnostic utility of microscopic quality assessment of sputum samples in the era of rapid syndromic PCR testing This is pushing labs to rethink old workflows.
Legionnaires’ Disease and Environmental Sources
Not all lung infections spread from person to person. Legionnaires’ disease, a severe form of pneumonia caused by Legionella bacteria, is acquired from environmental water sources. The organism lives in freshwater environments and proliferates in warm, stagnant water systems. It grows inside single-celled organisms within biofilms that coat pipes, cooling towers, and water storage tanks.18PubMed. Legionella: from environmental habitats to disease pathology, detection and control You become infected by breathing in contaminated water droplets or mist, not by drinking the water.
Outbreaks have been traced to an impressive range of sources. A systematic review ranked residential drinking water and car air-conditioner water leakage as definite sources, while soil, solar-heated water systems, and other plumbing configurations were considered probable or possible sources.19PubMed. Environmental sources of community-acquired legionnaires’ disease: A review Cases have also been documented in industrial workplaces, where potable water systems harboring Legionella were identified as the infection source.20PubMed. Legionnaires’ disease in the work environment: implications for environmental health Building water management programs that keep water temperatures outside the growth range of Legionella and reduce stagnation are the primary prevention strategy.
Drug Resistance in Lung Pathogens
Antibiotic resistance is increasingly complicating the treatment of bacterial lung infections. Among gram-negative bacteria, which are particularly common in hospital-acquired and ventilator-associated pneumonia, multi-drug resistance is alarmingly prevalent. The most frequently isolated resistant organisms are Acinetobacter baumannii, Klebsiella pneumoniae, and Pseudomonas aeruginosa, with Acinetobacter especially common in ventilator-associated cases. Many of these organisms show high resistance to commonly used antibiotics including ampicillin, tetracyclines, cephalosporins, and even carbapenems, which are often considered last-resort drugs.21PubMed Central. Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns
This is a practical problem for patients. When the initial antibiotic chosen does not cover the actual pathogen, outcomes worsen and mortality rises. Rapid diagnostic tools that can identify not just the organism but also its resistance genes are becoming an essential part of managing pneumonia, especially in intensive care units where drug-resistant infections cluster.
The Role of the Lung Microbiome
The lungs, once thought to be sterile, harbor their own resident community of microbes. This lung microbiome appears to act as a gatekeeper, helping to resist colonization by harmful pathogens and influencing the local immune environment.22Nature Reviews Microbiology. The microbiota of the respiratory tract: gatekeeper to respiratory health When that microbial community is disrupted, whether by antibiotics, illness, or mechanical ventilation, the door opens for pathogenic organisms to take hold.
Specific members of the respiratory microbiome seem to play protective roles. Certain anaerobic bacteria commonly found in the mouth and lungs, such as Prevotella and Veillonella, have been associated with better pneumonia outcomes and appear to activate immune defense pathways in the lower airways.23PubMed Central. Insights into the role of the respiratory tract microbiome in defense against bacterial pneumonia Disruption of the lung microbiome, such as through changes in microbial diversity and composition, has been linked to increased susceptibility to infections and a weakened innate immune response.24Signal Transduction and Targeted Therapy. Lung microbiome: new insights into the pathogenesis of respiratory diseases This is still an emerging field, but it may eventually inform strategies for preventing lung infections beyond just vaccines and hand hygiene.
Vaccines and the Decline in Lung Infection Deaths
The global death toll from lower respiratory infections has been falling steadily. Between 1990 and 2019, the worldwide mortality rate from non-COVID lower respiratory infections dropped by about 42%. During the pandemic years of 2020 and 2021, non-pharmaceutical interventions like masking and social distancing drove an additional 16% decline, with influenza deaths falling by roughly 72% and RSV deaths by about 67% during that period.1The Lancet Infectious Diseases. Global, regional, and national burden of lower respiratory infections and their aetiologies, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
Pneumococcal conjugate vaccines (PCVs) have been a major driver of this progress, particularly in children. Introduction of these vaccines led to substantial declines in hospitalization for pneumonia in young children, with outpatient rates of pneumonia dropping by about two-thirds and hospitalization rates falling by nearly half during the late PCV13 period.25PubMed Central. Differential Impact of Pneumococcal Conjugate Vaccines on Hospitalized Versus Outpatient Community-Acquired Alveolar Pneumonia in Children Younger Than 5 Years Suggests Differences in Pathogenesis An intriguing finding is that pneumococcal vaccines may also reduce hospitalizations from RSV-associated pneumonia, suggesting that bacterial co-infection with Streptococcus pneumoniae plays an important role in making RSV infections severe enough to require hospital care.26PubMed Central. Pneumococcal Conjugate Vaccines Are Protective Against Respiratory Syncytial Virus Hospitalizations in Infants: A Population-Based Observational Study
New RSV vaccines, approved in recent years for older adults and for maternal immunization to protect newborns, add another layer of prevention that did not exist a decade ago. Influenza vaccines, while imperfect in their year-to-year effectiveness, remain the primary tool for blunting the impact of seasonal flu on the lungs.
Long-Term Lung Damage After Infection
Some lung infections leave lasting structural damage even after the pathogen itself is gone. Bronchiectasis, a condition where airways become permanently widened and scarred, is one of the most common sequelae. It can develop after severe infections including tuberculosis, whooping cough, and adenoviral pneumonia.27PubMed. Pathophysiology, causes and genetics of paediatric and adult bronchiectasis The damaged airways lose their ability to clear mucus effectively, creating a vicious cycle: pooled mucus breeds more infections, which cause more damage, which leads to more mucus retention.
Post-infectious bronchiectasis is particularly common in low-resource settings where severe childhood infections may go partially treated or untreated. But it also affects adults in wealthier countries, especially those who have had NTM infections or recurrent pneumonias. Treatment focuses on airway clearance techniques, prompt antibiotic treatment of flare-ups, and sometimes long-term inhaled antibiotics to keep bacterial loads low. Once established, bronchiectasis does not reverse, making prevention and early treatment of the initial infection all the more important.
Avian Influenza and Emerging Threats
New lung infection threats continue to emerge from the animal world. Avian influenza viruses, particularly H5N1 and H7N9 subtypes, have repeatedly jumped from poultry to humans with high fatality rates. The concern is not just the sporadic human cases but the pandemic potential: if one of these viruses mutated to spread efficiently between people through respiratory droplets, it could trigger a global outbreak in a population with no pre-existing immunity.28PubMed Central. Avian influenza A viruses: from zoonosis to pandemic
The 2020–2023 period saw major epizootics of H5 avian influenza among birds and mammals worldwide, with new reassortant viruses emerging through genetic mixing as the virus circled through different animal species. A novel H3N8 avian influenza virus made a fatal jump to a human host in early 2023.29The Lancet Infectious Diseases. Changing epidemiology, global spread, and One Health control of avian influenza viruses Surveillance at the animal-human interface, stockpiling of candidate vaccines, and rapid genomic sequencing of new strains are the tools being used to monitor these threats. For the average person, the practical takeaway is to avoid contact with sick or dead wild birds and to follow public health advisories during reported poultry outbreaks.